Identification of Combinatorial Genomic Abnormalities Associated with Prostate …

Identification of Combinatorial Genomic Abnormalities Associated with Prostate …

Multiple biomarkers are needed to distinguish aggressive from indolent prostate cancer. We tested the prognostic utility of a three-marker fluorescent in situ hybridization panel (TMPRSS2/ERG rearrangements, AR gain, and PTEN deletion) in a

(Visited 1 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.